Nicola Laurieri

Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2

Angela J. Russell, Isaac M. Westwood, Matthew H. J. Crawford et al. · Bioorganic & Medicinal Chemistry · 2008 · 84 citations · Full text

Arylamine N-acetyltransferase 2, Breast Oncology, Medicine +9

Prospective virtual screening with Ultrafast Shape Recognition: the identification of novel inhibitors of arylamine<i>N</i>-acetyltransferases

Pedro J. Ballester, Isaac M. Westwood, Nicola Laurieri et al. · Journal of The Royal Society Interface · 2009 · 75 citations · Full text

Reaction mechanism of azoreductases suggests convergent evolution with quinone oxidoreductases

Ali Ryan, Chan-Ju Wang, Nicola Laurieri et al. · Protein & Cell · 2010 · 67 citations · Full text

PharmGKB summary

Daniel J. Klein, Sotiria Boukouvala, Ellen M. McDonagh et al. · Pharmacogenetics and Genomics · 2016 · 58 citations · Full text

Literary History, Literary Theory, Literary Study +8

From Arylamine N-Acetyltransferase to Folate-Dependent Acetyl CoA Hydrolase: Impact of Folic Acid on the Activity of (HUMAN)NAT1 and Its Homologue (MOUSE)NAT2

Nicola Laurieri, Julien Dairou, James E. Egleton et al. · PLoS ONE · 2014 · 56 citations · Full text

Chemical Biology, Arylamine N-acetyltransferase, Aldo-keto Reductase +15